A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed C-Kit Positive Acute Myeloid Leukemia (AML)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Advani, A; Cooper, B; Sowunmi, O; Elson, P; Ali-Osman, F; Park, J; Rao, A; Rizzieri, DA; Wang, ES; Cotta, C; Sekeres, MA; Kalaycio, M; Sobecks, R; Rouphail, B; Maciejewski, JP; Davis, R; Bailey, L; Foster, B; Rush, ML; Adams, D; Tse, W

Published Date

  • November 16, 2012

Published In

Volume / Issue

  • 120 / 21

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)

Conference Location

  • Atlanta, GA

Conference Start Date

  • December 8, 2012

Conference End Date

  • December 11, 2012